Loading…
Allarity Therapeutics, Inc. is projected to rise to $1.60 by 2027, a +37% move from its current price of $1.17. ALLR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $1.12 | $1.16 | $1.21 | -0.09% |
| Jul 15 | $1.10 | $1.16 | $1.23 | -0.18% |
| Jul 16 | $1.09 | $1.16 | $1.24 | -0.27% |
| Jul 17 | $1.08 | $1.16 | $1.25 | -0.36% |
| Jul 18 | $1.07 | $1.16 | $1.26 | -0.44% |
| Jul 19 | $1.06 | $1.16 | $1.27 | -0.53% |
| Jul 20 | $1.05 | $1.16 | $1.28 | -0.62% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.05 | $1.16 | $1.28 | -0.62% |
| Week 2 | $0.9981 | $1.15 | $1.33 | -1.24% |
| Week 3 | $0.9607 | $1.14 | $1.36 | -1.85% |
| Week 4 | $0.9293 | $1.14 | $1.39 | -2.46% |
| Week 5 | $0.9019 | $1.13 | $1.41 | -3.07% |
| Week 6 | $0.8773 | $1.12 | $1.44 | -3.67% |
| Week 7 | $0.8548 | $1.12 | $1.46 | -4.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Allarity Therapeutics, Inc. is a clinical-stage precision medicine pharmaceutical company focused on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. Its work centers on personalized cancer treatment using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology.
Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for advanced and recurrent ovarian cancer.
The company also develops stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida.
ALLR is currently priced at $1.20 per share with a market cap of $19.09M, ranking 4,847 by market capitalization. The near-term forecast shows a neutral stance in 2026 with an average price of $1.20 and a 0% ROI, followed by a bullish trajectory in the years that follow as averages rise and sentiment shifts to BULLISH. The 2027 forecast implies an average of $1.69 with a 41.1% ROI, and the path continues higher toward multi-year highs in the 2030s and 2040s, reaching an average of $6.48 by 2050 and a 440.1% ROI.
A major floor 35.8% below — a decisive break under it would weaken the trend.
The nearest floor, 3.0% below — buyers have tended to step in here.
The nearest ceiling, 47.6% above — a clean break opens room to run.
A major ceiling 65.5% above — clearing it would confirm fresh momentum.
Key ALLR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALLR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.17 | Sell | $1.19 | Sell |
| MA 10 | $1.24 | Sell | $1.23 | Sell |
| MA 20 | $1.31 | Sell | $1.31 | Sell |
| MA 50 | $1.45 | Sell | $1.37 | Sell |
| MA 100 | $1.30 | Sell | $1.36 | Sell |
| MA 200 | $1.27 | Sell | $274.44 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.17 | Neutral |
| Stoch RSI (14) | 40.33 | Neutral |
| CCI (20) | -119.24 | Sell |
| Williams %R (14) | -84.78 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -11.74 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 15.22 | Buy |
| TRIX (15) | -0.74 | Sell |
| Awesome (5,34) | -0.28 | Sell |
| Ultimate (7,14,28) | 30.60 | Neutral |
| Momentum (10) | -0.11 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 1.13 | Buy |
| ADX (14) | 19.42 | Neutral |
| ATR (14) | 0.05 | Info |
Near term technicals are NEUTRAL with RSI14 at 40. The SMA50 sits at $1.47 and the SMA200 at $1.27, placing price action around a key support at $1.20 and beneath a resistance at $1.77. The 30-day range spans from a low of $0.9249 to a high of $1.56. Annualized volatility is high at 80%, indicating notable short-term swings around the price level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.81 | $1.17 | $1.42 | 0% | Neutral | |
| $1.22 | $1.60 | $2.23 | +37% | Bullish | |
| $1.22 | $1.65 | $2.42 | +42% | Bullish | |
| $1.14 | $1.60 | $2.43 | +37% | Bullish | |
| $1.20 | $1.73 | $2.72 | +49% | Bullish | |
| $1.12 | $1.66 | $2.68 | +43% | Bullish | |
| $1.22 | $1.86 | $3.07 | +60% | Bullish | |
| $1.50 | $2.34 | $3.96 | +101% | Bullish | |
| $1.58 | $2.53 | $4.37 | +117% | Bullish | |
| $1.61 | $2.65 | $4.65 | +127% | Bullish | |
| $2.14 | $3.90 | $7.40 | +235% | Bullish | |
| $2.62 | $5.81 | $12.30 | +398% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.81 | $1.17 | $1.39 | +0.00% |
| August 2026 | $0.9084 | $1.08 | $1.33 | -7.00% |
| September 2026 | $0.8918 | $1.07 | $1.34 | -0.85% |
| October 2026 | $0.9242 | $1.12 | $1.42 | +4.52% |
| November 2026 | $0.9105 | $1.11 | $1.43 | -0.78% |
| December 2026 | $0.8916 | $1.10 | $1.42 | -1.41% |
Click any year to see its month-by-month ALLR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ALLR could reach as high as $1.42, with a base case around $1.17 and support toward $0.81 — roughly 0% from $1.17. Price action looks broadly range-bound.
Expect ALLR to range from $1.22 to $2.23 through 2027. The $1.60 average target implies a +37% move from current prices. That is up +37% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The ALLR price prediction for 2028 points to an average of $1.65 (low $1.22, high $2.42) — a potential gain of +42% on today's $1.17. Momentum favours further upside here.
In 2029, ALLR is projected to trade between $1.14 and $2.43, averaging $1.60 — a potential gain of +37% from today's $1.17. That is -3% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Allarity Therapeutics, Inc.'s 2030 outlook centres on $1.73, within a $1.20 to $2.72 range. That is up +8% on the projected 2029 average. That marks a +49% change versus current levels. Momentum favours further upside here.
By 2031, ALLR could reach as high as $2.68, with a base case around $1.66 and support toward $1.12 — roughly +43% from $1.17. Buyers look set to stay in control over this stretch.
Expect ALLR to range from $1.22 to $3.07 through 2032. The $1.86 average target implies a +60% move from current prices. That is up +12% on the projected 2031 average. Momentum favours further upside here.
The ALLR price prediction for 2033 points to an average of $2.34 (low $1.50, high $3.96) — a potential gain of +101% on today's $1.17. Buyers look set to stay in control over this stretch.
In 2034, ALLR is projected to trade between $1.58 and $4.37, averaging $2.53 — a potential gain of +117% from today's $1.17. That is up +8% on the projected 2033 average. Momentum favours further upside here.
Allarity Therapeutics, Inc.'s 2035 outlook centres on $2.65, within a $1.61 to $4.65 range. That is up +5% on the projected 2034 average. That marks a +127% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ALLR could reach as high as $7.40, with a base case around $3.90 and support toward $2.14 — roughly +235% from $1.17. Momentum favours further upside here.
Expect ALLR to range from $2.62 to $12.30 through 2050. The $5.81 average target implies a +398% move from current prices. That is up +49% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALLR today (≈ 858.369099 ALLR) could be worth
$4,984.05
+$3,984.05 (+398%) by 2050 · US Dollar
Based on the average projected ALLR price of $5.81 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALLRwould be worth at today's price.
$1,000 invested in ALLR on Jul 10, 2025 (≈ 925.925889 ALLR) would be worth
$1,078.7
+$78.7 (+7.9%) today · 1.08× · US Dollar
Based on a ALLR entry price of $1.08 vs. today's $1.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.31 | $889.31 | -11.1% |
| 1 month ago | $1.49 | $781.88 | -21.8% |
| 3 months ago | $1.27 | $917.32 | -8.3% |
| 6 months ago | $1.14 | $1,021.93 | +2.2% |
| 1 year ago | $1.08 | $1,078.7 | +7.9% |
| All time (4.6y) ago | $8,820,000 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALLR forecast.
Our base-case forecast reaches $2.30 around 2033.
Implied market cap at $2.30: $36.59M
The multi-year forecast paints a bullish trajectory after a neutral 2026, with sustained upside across the horizon. By 2027 the average price is projected at $1.69 and rises through subsequent years to an average of $1.85 in 2030, $2.56 in 2033, and $2.86 in 2035, with higher upside in the later years. The forecast shows a max path reaching $4.74 by 2034 and $5.09 by 2035, then accelerating to $8.13 in 2040 and $13.98 by 2050, with corresponding ROIs of 54.1% in 2030, 113% in 2033, 126.2% in 2034, 138.2% in 2035, 251.7% in 2040, and 440.1% in 2050.
The sentiment is consistently BULLISH from 2027 onward, reflecting an extended upside potential, though these are estimates and not guarantees and carry inherent uncertainty.
Tap a question to reveal the answer.
Avg $1.85, min $1.26, max $2.93, ROI 54.1%, sentiment BULLISH.
From 2027 onward the forecast shows BULLISH sentiment with rising averages (2027 avg $1.69; 2028 $1.73; 2030 $1.85; 2040 $4.22; 2050 $6.48) and positive ROI (e.g., 41.1% in 2027, 251.7% in 2040, 440.1% in 2050). The 2026 outlook is neutral, and these figures are estimates, not guarantees.
Yes. The forecast shows max values such as 2033 $4.37, 2034 $4.74, 2035 $5.09, 2040 $8.13, and 2050 $13.98.
$0.9249 to $1.56.
Current price $1.20; market cap $19.09M; rank 4847.
Allarity Therapeutics, Inc. Community Discussion
0Share your Allarity Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.